Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

April 06, 2024

There was unambigously good news about the company's single commercialized medication.

Why Amarin Stock Was Rocketing Higher on Wednesday

April 03, 2024

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

April 03, 2024

Company’s IP Protection for VAZKEPA® in Europe Now Extended Into 2039

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Earnings Scheduled For February 29, 2024

February 29, 2024

Via Benzinga

Why Amarin Stock Skyrocketed Today

January 10, 2024

The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

March 25, 2024

AMRN earnings call for the period ending December 31, 2023.

Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript

February 29, 2024

Amarin's Q4 2023 financials: Revenues at $74.71 million, beating consensus. US net product revenue is $64.9 million, down Y/Y. CEO Patrick Holt shares operational progress, including European market...

Topics Earnings

Why Is Amarin Stock Trading Lower After Q4 Earnings?

February 29, 2024

Via Benzinga

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

February 29, 2024

Amarin Corp PLC (NASDAQ: AMRN) shares are trading by around 28% after the company reported

Why Pharma Company Amarin Shares Are Zooming Today

January 10, 2024

Via Benzinga

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024

February 15, 2024

Amarin Chairman & CEO Issue Letter to Shareholders

January 22, 2024

Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

January 11, 2024

Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged...

Via Benzinga

Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday

January 11, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...

Via Benzinga

Topics Stocks

Crude Oil Falls 1%; Amarin Shares Spike Higher

January 10, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The...

Via Benzinga

Topics Stocks

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session

January 10, 2024

Via Benzinga

What's Going On With Amarin Stock?

January 10, 2024

Amarin Corporation (NASDAQ: AMRN) shares are trading higher Wednesday after the company released a business update and announced a conditional s

Via Benzinga

Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week

January 10, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

January 10, 2024

Via Benzinga

Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024

January 10, 2024

Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 11, 2023

New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline

12 Health Care Stocks Moving In Monday's After-Market Session

December 04, 2023

Via Benzinga

November 12, 2023

AMRN earnings call for the period ending September 30, 2023.

Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript

November 01, 2023

Topics Earnings

Amarin Reports Third Quarter 2023 Financial Results

November 01, 2023

Amarin Appoints Jonathan Provoost Executive Vice President, Chief Legal & Compliance Officer

October 31, 2023

Latest Research Evaluating VASCEPA®/VAZKEPA® (icosapent ethyl) and Subgroups from the REDUCE-IT Landmark Outcomes Trial to be Presented at the American Heart Association (AHA) Scientific Sessions 2023

October 26, 2023

-- Additional Mechanistic Data on Eicosapentaenoic Acid (EPA) and Real-World Characteristics of Patients with Diabetes on IPE Also Featured at the Meeting --